Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 1 regulatory inhibitor subunit 14C (PPP1R14C) is a protein that acts as a high-affinity inhibitor of protein phosphatase 1 (PP1), especially the catalytic subunit PPP1CA, by binding in a phosphorylation-dependent manner. Upon phosphorylation, particularly at threonine 72, PPP1R14C becomes over 600-fold more potent as an inhibitor, functioning as a molecular switch to regulate phosphorylation states of target proteins in cellular signaling. Biological roles attributed to PPP1R14C include regulation of signaling cascades essential for neuronal activity, metabolism, contraction, cell division, and its potential involvement in cancer and thyroid disorders. The protein is related to other PP1 regulatory inhibitors (such as CPI17 and PPP1R14B) and may be detected serologically in certain breast cancers as antigen NY-BR-81, implicating a possible role as a tumor biomarker[1][2][3][4][5][6].
Inhibition of protein phosphatase 1 (PP1) through phosphorylation-dependent binding to PP1 catalytic subunits, particularly PPP1CA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 1 regulatory inhibitor subunit 14C (PPP1R14C).